
PPD® in Greater China
PPD in Greater China: Building a Platform for Market Success
PPD’s team of 1,100+ professionals are on the ground in China helping you navigate the complex regulatory, cultural, linguistic and logistical challenges of planning and executing your drug development program in a rapidly evolving environment.
years on the ground in China
Employees and growing
Studies conducted
Successful submissions in past 5 years
Lab locations providing bioanalytical, biomarker, vaccine sciences and central lab services
Stop service with broad clinical development and laboratory capabilities
CLINICAL DEVELOPMENT
PPD offers proven solutions, ranging from early development to post-approval services, to ensure your product’s success:
PPD® LABORATORIES
PPD’s central lab in Shanghai provides service and quality data without compromises. Our new multi-functional lab in Suzhou (coming in 2021) will expand our local capabilities to help you make faster and more informed decisions:
- Central Lab
- Bioanalytical Lab
- Biomarker Lab
- Vaccine Sciences Lab
STRONG THERAPEUTIC EXPERIENCE AND MEDICAL EXPERTISE ALIGNED WITH YOUR PIPELINE
PPD has conducted 330+ studies in China, supported by a global powerhouse of 26,000+ clinical, scientific, and operational professionals worldwide.
HOW WE HELP IN CHINA
CONTACT PPD IN CHINA
We are ready to partner with you to help drive clinical trials and explore opportunities in China.